Entheon Biomedical Corp.
ENTBF
$0.08
-$0.001-1.24%
OTC PK
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -233.20K | -226.20K | -250.10K | -207.30K | -222.50K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -3.90K | 2.20K | 6.80K | -2.30K |
| Change in Net Operating Assets | -27.80K | 1.90K | -12.70K | 2.80K | -42.70K |
| Cash from Operations | -261.10K | -228.20K | -260.50K | -197.50K | -267.30K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 6.90K | 18.20K | 18.20K | 18.20K |
| Cash from Investing | -- | 6.90K | 18.20K | 18.20K | 18.20K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 147.50K | 147.50K | 147.50K | -- | -- |
| Repurchase of Common Stock | -147.50K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 147.50K | -- | -- | -- | -- |
| Cash from Financing | 108.20K | 108.20K | 108.20K | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -9.30K | -200.00 | -200.00 |
| Net Change in Cash | -152.90K | -113.10K | -143.50K | -179.60K | -249.40K |